digitalstudios2026-07-01T07:45:46+00:00Ipsen to acquire Memo Therapeutics AG, adding first-in-class BK polyomavirus antibody, expanding rare disease portfolio
digitalstudios2026-07-01T07:40:03+00:00Santhera Notes Topline Results from Catalyst Pharmaceuticals’ Phase 1 Clinical Study of AGAMREE®
digitalstudios2026-07-01T07:33:53+00:00Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division
